THELMA Therapeutics Co., Ltd. announced a private placement of common shares for gross proceeds of KRW 4,999,999,900 on December 20, 2021. The transaction will include participation from new investor H-TREPORT for 34.68% stake in the company. The company will receive funding through third party allotment of capital.
THELMA Therapeutics Co., Ltd.
Equities
A015540
KR7015540008
Other Specialty Retailers
1st Jan change | Capi. | |
---|---|---|
+12.45% | 6.28B | |
-16.69% | 4.13B | |
+6.45% | 3.84B | |
-7.52% | 1.72B | |
-2.61% | 1.61B | |
-14.93% | 1.27B | |
-23.08% | 1.07B | |
-40.16% | 772M | |
+3.81% | 665M |